Rudi Mariën

Rudi M.
Mariën is the founder of Fujirebio Europe NV, BARC SCS, Fujirebio US, Inc. He currently holds multiple positions including President & Chief Executive Officer at Biovest CVA since 2010, President & Chief Executive Officer at Gengest BVBA since 2009, Director at MyCartis NV, Non-Executive Director at Biocartis SA since 2012, Managing Director at LMA BVBA, Director at DSJ Bruxelles NV since 2013, Director at Oystershell NV, Director at Argon CVA, Director at Immo St-Michel NV, Director at PharmaFluidics NV, Director at Antelope Dx BV, and Member at American Association for Clinical Chemistry, Inc. Mr. Mariën has previously held positions as Chief Executive Officer & Director at BARC South Africa Pty Ltd., Chief Executive Officer & Director at Barc USA, Inc., Chief Executive Officer & Director at Laboraco BVBA, Chairman at Biocartis Group NV from 2017 to 2018, Director at Pacira CryoTech, Inc., Non-Independent Non-Executive Director at MDxHealth SA from 2011 to 2022, Independent Non-Executive Director at Quest for Growth NV in 2012, Director at deVGen NV from 2009 to 2010, Director at Intrexon ActoBiotics NV, Director at PharmaNeuroBoost NV, President & Managing Director at Biovest NV, Director at JenaValve Technology, Inc., Non-Executive Director at Multiplicom NV, Director at Biotalys NV, and Vice President at Cerba HealthCare SASU.
Mr. Mariën completed his undergraduate degree at Ghent University.